Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
130.67
-0.78 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
130.89
+0.22 (0.17%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.91 billion as of April 28, 2026. Its market cap has increased by 1,035.65% in one year.
Market Cap
1.91B
Enterprise Value
1.89B
1-Year Change
1,035.65%
Ranking
Category
Stock Price
$130.67
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.91B, an increase of 862.80%. That is a compound annual growth rate of 226.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.91B | 66.12% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.03B |
| Trevi Therapeutics | 2.02B |
| Stoke Therapeutics | 2.01B |
| Syndax Pharmaceuticals | 1.89B |
| Galapagos NV | 1.88B |
| Pharvaris | 1.87B |
| Recursion Pharmaceuticals | 1.85B |
| Taysha Gene Therapies | 1.84B |